Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The phrase "phlegm resolution via multi-herb synergy" refers to a traditional Chinese medicine approach in which multiple herbs are combined to synergistically enhance the resolution of phlegm, most commonly in respiratory diseases. This strategy aims to produce therapeutic effects through interactions at multiple biological pathways rather than targeting a single molecular entity. Studies show that such combinations can modulate diverse targets, including pathways regulating mucin family proteins, cytokine receptor signaling, the MAP kinase cascade, and immune responses, which collectively impact mucus generation, clearance, and airway inflammation[3][7][9]. However, "multi-herb synergy" is a pharmacological principle rather than a defined molecular target or receptor and should not be considered a canonical drug target within databases focused on gene or protein targets.
Regulation of cytokine and chemokine receptor pathways, MAPK pathway modulation, Modulation of mucin production and secretion, Multi-pathway antiviral and anti-inflammatory actions
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Phlegm resolution via multi-herb synergy.